Chika Nwachukwu
Papers
2
Total Citations
7
H-Index
2
About
Dr. Chika Nwachukwu is a radiation oncologist whose research focuses on advancing stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. Her work centers on developing and refining single-fraction ablative radiotherapy techniques, aiming to reduce treatment burden while maintaining efficacy. Dr. Nwachukwu has made significant contributions through her leadership of phase I dose-escalation trials, including a multi-institutional study that established the safety and feasibility of single-fraction S-PBI. Her 2023 paper on a pre-operative single-fraction ablative trial, with 4 citations, and her 2021 multi-institutional trial report, with 3 citations, represent foundational steps in this emerging field. These studies have helped define optimal dosing and patient selection, paving the way for larger phase II/III investigations. Her work is particularly notable for its potential to transform breast cancer treatment by offering a non-invasive, one-day alternative to weeks of conventional radiation. Dr. Nwachukwu’s research is highly relevant for clinicians and researchers seeking to minimize toxicity and improve patient convenience in early-stage breast cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2